IJR News — today's news from every sideMarcus Bell Sanders being doubtful adds pressure on the defensive line to hold up without extra depth. Nicole Hardy I don't see why we need another presidential getaway when the existing one already serves its purpose fine. Elena Vasquez Unannounced Camp David meetings on Iran and Yemen suggest the administration is weighing major military or diplomatic steps soon. Derek Foss I drive it twice a week and the potholes are dangerous. Glad someone famous is finally saying it out loud. Derek Foss The front office did well landing those pieces but they need to prove it on the court to keep a star like him around. Marcus Bell The 2026 rematch looks interesting if Cal can tighten up at home against a Clemson team that travels well. Rachel Meyers O’Brien stepping into the VP finance role keeps continuity while adding fresh leadership at the top. Derek Foss Hollis threw for 192 yards and that one score was enough to hold off the Bobcats. Marcus Bell An overnight Camp David trip feels brief, maybe it was just to clear his head before diving back into work. Dr. David Crean Book Guides Biopharma Leaders on Commercialization — Sep 18, 2026A new book, Dual Fluency: Bridging Science, Capital, and Governance in Life Sciences by Dr. David H. Crean, offers a practical blueprint for biopharma to move from discovery to commercialization by focusing on three core translations—Data to Capital, Discovery to Deal, and Bench to Boardroom—along with Capital Stack Optimization. Aimed at scientist-founders, pre-commercial CEOs, BD executives, and investors, the work promises actionable risk-reduction insights and will be available on Amazon and major bookstores through Cardiff Advisory LLC.
Jared Kim This book seems helpful for scientist founders who struggle turning research into actual funding and governance plans.
